abstract |
Use of therapeutically effective amounts of a bronchodilator and a sulfated polysaccharide, in which the sulfated polysaccharide is a low molecular weight heparin (LMWH) or an ultra low molecular weight heparin (ULMWH) for the preparation of a pharmaceutical composition to prevent tolerance to a bronchodilator in a mammal. |